• OKI and ARC Innovation Center at Sheba Join Forces to Prevent Dementia

    OKI and ARC Innovation Center at Sheba (Sheba), the largest medical facility in the Middle East, have agreed to pursue

    Read More
  • Targovax Granted European Patent for Mutant-RAS Neoantigen Platform Lead Products

    Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid

    Read More
  • EXPAREL Achieves Statistically Significant Reductions in Opioid Consumption and Pain Scores in Cesarean Section Patients

    Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that its Phase 4 study of EXPAREL® (bupivacaine liposome injectable suspension) in patients undergoing

    Read More
  • Apraglutide Gets Orphan Drug Designation for Short Bowel Syndrome

    The Food and Drug Administration (FDA) has granted Orphan Drug designation to apraglutide (Therachon AG), an investigational treatment for short

    Read More
  • Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management

    Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced the Sharesource remote patient management platform has performed more

    Read More


error: Content is protected !!